Finasteride is a 5-alpha reductase inhibitor, a hormone-blocking medicine, that compounding pharmacies prepare as oral capsules and topical scalp solutions or foams.
Finasteride is a synthetic 4-azasteroid that competitively inhibits type II 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). Lower DHT in the scalp and prostate is the basis for its labeled uses. Two manufactured coated tablets exist from Organon: Proscar, FDA-approved for symptomatic benign prostatic hyperplasia in men, and Propecia, FDA-approved for male pattern hair loss in men only. Neither is approved for women or children, and no topical finasteride is FDA-approved. Prescribers may order finasteride compounded when they want a strength between the two manufactured tablets, a topical scalp preparation (often combined with minoxidil), or a capsule free of a specific dye or filler. Compounded preparations are not FDA-approved and require a prescription.
The Propecia and Proscar labels carry no boxed warning. Finasteride is contraindicated in pregnancy and is not indicated for women or children. Women who are pregnant or may become pregnant should not handle crushed or broken tablets, because the drug can cause abnormal development of the external genitals in a male fetus; if contact occurs, wash the area with soap and water, and ask your pharmacist how to handle compounded forms. Reported side effects include decreased libido, erectile dysfunction, ejaculation problems, testicle pain, breast tenderness or enlargement and, after marketing, depression, suicidal thoughts, male breast cancer and sexual dysfunction that continued after stopping. In April 2025, FDA alerted health care providers, compounders and consumers that it had received reports of adverse events with compounded topical finasteride, including erectile dysfunction, anxiety, depression and suicidal thoughts, and that most reports described events that continued after the product was stopped. Finasteride lowers PSA, so tell any lab or prescriber you take it. The label identifies no drug interactions of clinical importance. It is not known whether finasteride passes into breast milk. If side effects are severe or do not go away, talk to your prescriber or pharmacist.
Finasteride competitively inhibits type II (and III) 5-alpha reductase with minimal type I selectivity, lowering scalp and serum DHT. Oral bioavailability is about 65 percent and unaffected by food; protein binding is about 90 percent; hepatic metabolism is mainly via CYP3A4 to metabolites with less than 20 percent of parent activity; terminal half-life is roughly 5 to 6 hours, longer in men over 70. Labeled indications: Proscar for benign prostatic hyperplasia and Propecia for male pattern hair loss, both in men only. Prescribers have ordered compounded topical finasteride, alone or with minoxidil, for androgenetic alopecia in men and women; a 2018 systematic review in the Journal of Drugs in Dermatology reported reduced scalp and plasma DHT with topical use, called the evidence preliminary, and noted that only oral finasteride and topical minoxidil are FDA-approved for this indication. In an April 22, 2025 alert, FDA reported 32 adverse event cases with compounded topical finasteride received from 2019 to 2024, with events similar to those seen with oral finasteride, and noted a greater potential risk of inadvertent exposure to others, specifically females, through transfer of the product. Off-label oral uses in the literature include hirsutism and adjunctive use in transgender women. Dosing and route are per prescriber. Monitoring: baseline PSA, since measured values fall on treatment and any confirmed rise from the nadir warrants evaluation; mood and sexual function; blood donation is deferred during and for months after treatment. Pregnancy Category X on the label.
Compounded at Bayview
Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.
For prescribers
Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.